SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950123-20-006736
Filing Date
2020-07-06
Accepted
2020-07-06 21:00:43
Documents
1
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4.html 4  
1 PRIMARY DOCUMENT doc4.xml 4 10897
  Complete submission text file 0000950123-20-006736.txt   12212
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Weissman James B (Reporting) CIK: 0001598480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 201015041